Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)

NYL Ngoi, TZ Tan, KT Kuay, ACY Tan, JY Lee, MY Pang, KW Tham, J Chan, WL Wong, WY Chay, D Anne, M Friedlander, S Varma, T Meniawy, G Au-Yeung, C Scott, L Mileshkin, D Bowtell, RY-J Huang, DSP Tan